Laces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO world

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

(2018) Patrick N. A. Harris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review

(2017) Jennifer McDanel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

(2016) Belén Gutiérrez-Gutiérrez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae : a pooled analysis of Phase 3 clinical trials

(2016) Myra W. Popejoy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?

(2015) Patrick N A Harris et al.   LANCET INFECTIOUS DISEASES

Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae

(2013) Milena McLaughlin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli

(2013) Pilar Retamar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

(2013) Brian VanScoy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

(2012) T. W. Felton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests

(2012) Dror Marchaim et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

(2011) J. Rodriguez-Bano et al.   CLINICAL INFECTIOUS DISEASES

Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: A matched case–control study

(2011) Hong-Jyun Chang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES